Literature DB >> 30710822

Drugs/lamellae interface influences the inner structure of double-loaded liposomes for inhaled anti-TB therapy: An in-depth small-angle neutron scattering investigation.

Eleonora Truzzi1, Fiorella Meneghetti2, Matteo Mori2, Luca Costantino1, Valentina Iannuccelli1, Eleonora Maretti1, Fabio Domenici3, Carlo Castellano4, Sarah Rogers5, Angela Capocefalo6, Eliana Leo7.   

Abstract

With the aim of developing new drug carriers for inhalation therapy, we report here an in depth investigation of the structure of multilamellar liposomes loaded with two well-established anti-tubercular (anti-TB) drugs, isoniazid (INH) and rifampicin (RIF), by means of small-angle neutron-scattering (SANS) analysis. Unloaded, single drug-loaded and co-loaded liposomes were prepared using different amounts of drugs and characterized regarding size, encapsulation efficiency and drug release. Detailed information on relevant properties of the investigated host-guest structures, namely the steric bilayer thickness, particle dispersion, number of lamellae and drug localization was studied by SANS. Results showed that RIF-liposomes were less ordered than unloaded liposomes. INH induced a change in the inter-bilayer periodical spacing, while RIF-INH co-loading stabilized the multilamellar liposome architecture, as confirmed by the increment of the drug loading capacity. These findings could be useful for the understanding of in vitro and in vivo behavior of these systems and for the design of new drug carriers, intended for inhaled therapy.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drugs-lamellae interactions; Isoniazid; Multilamellar liposomes; Rifampicin; Small-angle neutron scattering

Mesh:

Substances:

Year:  2019        PMID: 30710822     DOI: 10.1016/j.jcis.2019.01.094

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  1 in total

1.  Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections.

Authors:  Matteo Mori; Giovanni Stelitano; Anna Griego; Laurent R Chiarelli; Giulia Cazzaniga; Arianna Gelain; Elena Pini; Marina Camera; Paola Canzano; Andrea Fumagalli; Edoardo Scarpa; Chiara Cordiglieri; Loris Rizzello; Stefania Villa; Fiorella Meneghetti
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.